AR045423A1 - Combinaciones de analiticos y antidepresivos - Google Patents

Combinaciones de analiticos y antidepresivos

Info

Publication number
AR045423A1
AR045423A1 ARP040101623A ARP040101623A AR045423A1 AR 045423 A1 AR045423 A1 AR 045423A1 AR P040101623 A ARP040101623 A AR P040101623A AR P040101623 A ARP040101623 A AR P040101623A AR 045423 A1 AR045423 A1 AR 045423A1
Authority
AR
Argentina
Prior art keywords
fluoxetine
antidepressants
paroxetine
antidepressant
hydrochloride
Prior art date
Application number
ARP040101623A
Other languages
English (en)
Inventor
Rodney J Hughes
Howard Hassman
Original Assignee
Cephalon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cephalon Inc filed Critical Cephalon Inc
Publication of AR045423A1 publication Critical patent/AR045423A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Composiciones y métodos para el tratamiento de trastornos depresivos mediante administración de modafinilo con antidepresivos. Reivindicación 10: Un método para reducir el tiempo de aparición del efecto de un antidepresivo usado en terapia farmacológica en un sujeto animal, que consiste en administrar al sujeto una cantidad efectiva de modafinilo Reivindicación 11: El método de la reivindicación 10, donde el antidepresivo es fluoxetina y/o paroxetina y/o citalipram. Reivindicación 17: El método de la reivindicación 11, donde el antidepresivo es seleccionado entre el grupo consistente en citalipram, fluoxetina, clorhidrato de fluoxetina, paroxetina, clorhidrato de paroxetina y/o clorhidrato de clomipramina.
ARP040101623A 2003-05-13 2004-05-11 Combinaciones de analiticos y antidepresivos AR045423A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46994303P 2003-05-13 2003-05-13
US10/844,187 US20040229942A1 (en) 2003-05-13 2004-05-12 Analeptic and antidepressant combinations

Publications (1)

Publication Number Publication Date
AR045423A1 true AR045423A1 (es) 2005-10-26

Family

ID=33423928

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040101623A AR045423A1 (es) 2003-05-13 2004-05-11 Combinaciones de analiticos y antidepresivos

Country Status (25)

Country Link
US (1) US20040229942A1 (es)
EP (1) EP1628652B1 (es)
JP (1) JP5553955B2 (es)
KR (1) KR20060019537A (es)
AR (1) AR045423A1 (es)
AU (1) AU2004238379B2 (es)
BR (1) BRPI0411174A (es)
CA (1) CA2525524C (es)
CY (1) CY1113154T1 (es)
DK (1) DK1628652T3 (es)
EA (1) EA012173B1 (es)
ES (1) ES2390225T3 (es)
HK (1) HK1087645A1 (es)
HR (1) HRP20120713T1 (es)
IS (1) IS8097A (es)
MX (1) MXPA05012144A (es)
MY (1) MY140179A (es)
NO (1) NO334448B1 (es)
NZ (1) NZ544135A (es)
PL (1) PL1628652T3 (es)
PT (1) PT1628652E (es)
SI (1) SI1628652T1 (es)
TW (1) TWI409061B (es)
UA (1) UA89753C2 (es)
WO (1) WO2004100937A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100729298B1 (ko) * 2000-07-27 2007-06-18 테바 파마슈티컬 인더스트리즈 리미티드 결정질의 순수한 모다피닐 및 이의 제조 방법
US6992219B2 (en) * 2002-08-09 2006-01-31 Cephalon France Modafinil polymorphic forms
US20040229941A1 (en) * 2003-05-13 2004-11-18 Cephalon, Inc. Analeptic and antidepressant combinations
AR045314A1 (es) * 2003-05-13 2005-10-26 Cephalon Inc Composiciones farmaceuticas de analepticos y antidepresivos
US20040242698A1 (en) * 2003-05-13 2004-12-02 Cephalon Inc. Analeptic and antidepressant combinations
US20040229943A1 (en) * 2003-05-16 2004-11-18 Cephalon Inc Analeptic and drug combinations
US7368591B2 (en) 2003-09-19 2008-05-06 Cephalon France Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation
US20090123545A1 (en) * 2005-07-21 2009-05-14 Ron Eyal S Rapid Onset and Short Term Modafinil Compositions and Methods of Use Thereof
DK2056811T3 (en) * 2006-08-14 2018-05-22 Neurohealing Pharmaceuticals Inc Modafinil-based treatment for premature ejaculation
JP6614014B2 (ja) * 2016-04-26 2019-12-04 信越化学工業株式会社 含窒素オルガノキシシラン化合物およびその製造方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2593809B1 (fr) * 1986-01-31 1988-07-22 Lafon Labor Benzhydrylsulfinylacetamide, procede de preparation et utilisation en therapeutique
FR2663225B1 (fr) * 1990-06-14 1994-11-04 Lafon Labor Nouvelle utilisation du modafinil.
FR2684875B1 (fr) * 1991-12-13 1995-05-24 Lafon Labor Utilisation du modafinil pour la fabrication d'un medicament ayant un effet anti-ischemique.
FR2697162B1 (fr) * 1992-10-23 1995-01-13 Lafon Labor Utilisation du modafinil pour la fabrication d'un médicament pour le traitement de l'incontinence urinaire et des troubles sphinctériens urétro vésicaux.
FR2706767B1 (es) * 1993-06-22 1995-09-08 Lafon Labor
US5933841A (en) * 1996-05-17 1999-08-03 Ameritech Corporation Structured document browser
US5890172A (en) * 1996-10-08 1999-03-30 Tenretni Dynamics, Inc. Method and apparatus for retrieving data from a network using location identifiers
FR2771004B1 (fr) * 1997-11-19 2000-02-18 Inst Curie Utilisation de derives de benzhydryl sulfinyle pour la fabrication de medicaments ayant un effet eveillant dans des situations de troubles de la vigilance d'origine medicamenteuse
US6359635B1 (en) * 1999-02-03 2002-03-19 Cary D. Perttunen Methods, articles and apparatus for visibly representing information and for providing an input interface
US6346548B1 (en) * 1999-08-16 2002-02-12 Cephalon, Inc. Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue
US6455588B1 (en) * 1999-08-20 2002-09-24 Cephalon, Inc. Compositions including modafinil for treatment of eating disorders and for appetite stimulation
US6503950B1 (en) * 1999-08-23 2003-01-07 David M. Ockert Triple drug therapy for the treatment of narcotic and alcohol withdrawal symptoms
US20010034373A1 (en) * 2000-02-09 2001-10-25 Matthew Miller Low dose modafinil for enhancement of cognitive function
US6417184B1 (en) * 2000-09-19 2002-07-09 David M. Ockert Triple drug therapy for the treatment and prevention of acute or chronic pain
US20030036555A1 (en) * 2001-08-03 2003-02-20 Boehringer Ingelheim Pharma Kg Pramipexole for the treatment of ADHD
US20040242698A1 (en) * 2003-05-13 2004-12-02 Cephalon Inc. Analeptic and antidepressant combinations
AR045314A1 (es) * 2003-05-13 2005-10-26 Cephalon Inc Composiciones farmaceuticas de analepticos y antidepresivos
US20040229941A1 (en) * 2003-05-13 2004-11-18 Cephalon, Inc. Analeptic and antidepressant combinations
US20040229943A1 (en) * 2003-05-16 2004-11-18 Cephalon Inc Analeptic and drug combinations

Also Published As

Publication number Publication date
BRPI0411174A (pt) 2006-07-18
CA2525524A1 (en) 2004-11-25
EP1628652B1 (en) 2012-07-11
JP5553955B2 (ja) 2014-07-23
PL1628652T3 (pl) 2012-12-31
AU2004238379B2 (en) 2009-08-20
EA200501802A1 (ru) 2006-06-30
AU2004238379A1 (en) 2004-11-25
IS8097A (is) 2005-10-27
TWI409061B (zh) 2013-09-21
DK1628652T3 (da) 2012-10-08
HK1087645A1 (en) 2006-10-20
NO334448B1 (no) 2014-03-03
JP2007505156A (ja) 2007-03-08
EA012173B1 (ru) 2009-08-28
EP1628652A1 (en) 2006-03-01
UA89753C2 (ru) 2010-03-10
ES2390225T3 (es) 2012-11-07
NZ544135A (en) 2008-09-26
KR20060019537A (ko) 2006-03-03
WO2004100937B1 (en) 2006-12-21
NO20055450L (no) 2006-02-01
TW200500063A (en) 2005-01-01
SI1628652T1 (sl) 2012-11-30
CY1113154T1 (el) 2016-04-13
WO2004100937A1 (en) 2004-11-25
NO20055450D0 (no) 2005-11-17
CA2525524C (en) 2012-09-25
PT1628652E (pt) 2012-09-28
US20040229942A1 (en) 2004-11-18
HRP20120713T1 (hr) 2012-09-30
MXPA05012144A (es) 2006-02-08
MY140179A (en) 2009-11-30

Similar Documents

Publication Publication Date Title
AR109605A2 (es) Método para tratar enfermedades vasculares periféricas, composición y utilización
AR044007A1 (es) Metodos para el tratamiento de la enfermedad de parkinson
CO5670327A2 (es) Procedimiento para el tratamiento de trastornos de depresion y ansiedad mediante terapia de combinacion
ATE506059T1 (de) Therapie zur behandlung der überaktiven blase
CY1118179T1 (el) Φαρμακευτικη συνθεση
KR980000447A (ko) 미르타자핀과 하나 이상의 선택적인 세로토닌 재이용 저해제로 이루어진 약학 조성물
BR112022019085A2 (pt) Uso de agentes para tratamento de condições respiratórias
AR074313A1 (es) Metodo para tratar o prevenir la trombosis utilizando etexilato de dabigatran o una sal del mismo. uso. kit
HRP20120713T1 (hr) Kombinacija analeptičkog modafinila i antidepresiva za liječenje depresije
ATE318135T1 (de) Verwendung von dapoxetin, a selektiver serotonin- aufnahme inhibitor mit schnellem wirkungseintritt,zur behandlung von sexueller dysfunction
CL2011001093A1 (es) Compuestos derivados de 4-[2-(2-fluorofenoximetil)fenil]piperidina, inhibidores de la recaptacion de serotonina y norepinefrina; procedimiento de preparacion; composicion farmaceutica que los comprende; y su uso para tratar el dolor neuropatico, fibromialgia, trastorno depresivo y obesidad entre otras.
EA200501821A1 (ru) Фармацевтическая комбинация, содержащая модафинил и другой лекарственный препарат
AR052152A1 (es) Producto farmaceutico para el tratamiento preventivo y terapeutico de trastornos del sueno
CO6280474A2 (es) Composicion farmaceutica para el tratamiento de la eyaculacion precoz
WO2004100939B1 (en) Combination of the analeptic modafinil and an antidepressant for the treatment of depression
AR047716A1 (es) Combinaciones de analepticos y antidepresivos
AR045314A1 (es) Composiciones farmaceuticas de analepticos y antidepresivos
BRPI0507745A (pt) compostos de azetidina substituìda como inibidores de ciclooxigenase-1-ciclooxigenase-2, processo para a sua preparação, medicamentos e seus usos
BRPI0413750A (pt) uso de loxapina ou de um seu sal farmaceuticamente aceitável, composição farmacêutica, e, kit
EA202190247A1 (ru) ПРИМЕНЕНИЕ рГЦ СТИМУЛЯТОРОВ ДЛЯ ЛЕЧЕНИЯ МИТОХОНДРИАЛЬНЫХ ЗАБОЛЕВАНИЙ
CO2023006028A2 (es) Formulación combinada oral que incluye gemigliptina y dapagliflozina y método de preparación para la misma
AR127946A1 (es) ESTIMULADOR TREG SELECTIVO RUR₂₀ₖD-IL-2 Y COMPOSICIONES RELACIONADAS
CL2004001042A1 (es) Metodo para aumentar la actividad de un antidepresivo en un sujeto animal que consiste en tratar al sujeto con modafinilo.
AR085483A1 (es) Tratamiento de enfermedad de deficit de atencion con hiperactividad, metodo de tratamiento, combinacion farmaceutica
AR063530A1 (es) Procedimiento de utilizacion de enoxaparina sodica para la preparacion de un medicamento

Legal Events

Date Code Title Description
FB Suspension of granting procedure